<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>FAH Hospital Policy Blog &#187; Transparency</title>
	<atom:link href="http://fahpolicy.org/category/transparency/feed/" rel="self" type="application/rss+xml" />
	<link>http://fahpolicy.org</link>
	<description>Perspectives on health policy affecting America&#039;s hospitals and the patients we serve</description>
	<lastBuildDate>Wed, 09 Sep 2015 19:58:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=4.2.4</generator>
	<item>
		<title>FAH Recommends FTC Re-Examine Anticompetitive Effects of Corporate Practice of Medicine Doctrine</title>
		<link>http://fahpolicy.org/fah-recommends-ftc-re-examine-anticompetitive-effects-of-corporate-practice-of-medicine-doctrine/</link>
		<comments>http://fahpolicy.org/fah-recommends-ftc-re-examine-anticompetitive-effects-of-corporate-practice-of-medicine-doctrine/#comments</comments>
		<pubDate>Thu, 05 Jun 2014 12:00:20 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog Team]]></dc:creator>
				<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=1132</guid>
		<description><![CDATA[The letter submitted by the FAH in response to the Federal Trade Commission’s March 2014 Examining Health Care Competition workshop centers on price and quality transparency. It also includes our recommendations on a third, critically important issue: the corporate practice of medicine. The FAH believes the FTC should reexamine the anti-competitive effects of the corporate practice of medicine doctrine. Defined as “the practice of corporations hiring physicians for purposes of generating profits”,  state corporate practice of medicine restrictions have been in place since the turn of the 20th century. While these restrictions are intended to protect the public from corporate [...] <a href="http://fahpolicy.org/fah-recommends-ftc-re-examine-anticompetitive-effects-of-corporate-practice-of-medicine-doctrine/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/fah-recommends-ftc-re-examine-anticompetitive-effects-of-corporate-practice-of-medicine-doctrine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chip Kahn Q&amp;A with Nathaniel Weixel of Bloomberg BNA</title>
		<link>http://fahpolicy.org/chip-kahn-qa-with-nathaniel-weixel-of-bloomberg-bna/</link>
		<comments>http://fahpolicy.org/chip-kahn-qa-with-nathaniel-weixel-of-bloomberg-bna/#comments</comments>
		<pubDate>Fri, 30 May 2014 18:50:46 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog Team]]></dc:creator>
				<category><![CDATA[Media]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=1124</guid>
		<description><![CDATA[The FAH has been very active in the past few weeks, as current FAH Chairman David T. Vandewater (President and CEO of Ardent Health Systems) and FAH Chair-Elect Keith B. Pitts (Vice Chairman of Tenet Healthcare Corporation) participated individually in separate panel discussions. Both of these panels were based primarily upon critical policy journal articles addressing hospital realignment and market competition and authored by several academicians also participating as panelists. Additionally, FAH President and CEO Chip Kahn recently was interviewed for a Q&#38;A feature article by reporter Nathaniel Weixel of Bloomberg BNA. The Q&#38;A, published today, covers a broad number [...] <a href="http://fahpolicy.org/chip-kahn-qa-with-nathaniel-weixel-of-bloomberg-bna/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/chip-kahn-qa-with-nathaniel-weixel-of-bloomberg-bna/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The FAH Weighs in on Health Care and Competition</title>
		<link>http://fahpolicy.org/the-fah-weighs-in-on-health-care-and-competition/</link>
		<comments>http://fahpolicy.org/the-fah-weighs-in-on-health-care-and-competition/#comments</comments>
		<pubDate>Thu, 29 May 2014 19:28:32 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog Team]]></dc:creator>
				<category><![CDATA[Realignment]]></category>
		<category><![CDATA[Transparency]]></category>
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=1119</guid>
		<description><![CDATA[This afternoon, the National Academy of Social Insurance (NASI) hosted a panel featuring Keith Pitts, Vice Chairman of Tenet Healthcare Corporation and Chair-Elect of the Board of Directors of the Federation of American Hospitals.  Pitts is the second FAH representative in just two weeks to have the opportunity to speak on a panel focusing on the important topic of competition in healthcare.  The FAH is pleased that the voice of hospital systems and our esteemed leadership is included in these critical discussions. With his extensive experience in financial and operational management of health care systems, Pitts was the only panelist [...] <a href="http://fahpolicy.org/the-fah-weighs-in-on-health-care-and-competition/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/the-fah-weighs-in-on-health-care-and-competition/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FAH Outlines Recommendations on Price &amp; Quality Transparency</title>
		<link>http://fahpolicy.org/fah-outlines-recommendations-on-price-quality-transparency/</link>
		<comments>http://fahpolicy.org/fah-outlines-recommendations-on-price-quality-transparency/#comments</comments>
		<pubDate>Thu, 29 May 2014 12:00:01 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog Team]]></dc:creator>
				<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=1116</guid>
		<description><![CDATA[A letter to the Federal Trade Commission (FTC), recently sent from the FAH, addressed two issues of crucial importance when building efficient and competitive markets: price and quality transparency. Price Transparency Price transparency is necessary in order for patients to easily determine the cost of their premiums, deductibles, copayments and non-covered services (“Out-of-Pocket Costs”) prior to purchasing health insurance coverage and receiving medical services. Our letter outlines five key principles from the Healthcare Financial Management Association Price Transparency Task Force that the FAH believes are critical to defining price transparency. Under these principles, price transparency should: Enable patients to make [...] <a href="http://fahpolicy.org/fah-outlines-recommendations-on-price-quality-transparency/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/fah-outlines-recommendations-on-price-quality-transparency/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FAH Weighs in with Antitrust Agency on Health Care Competition and Transparency</title>
		<link>http://fahpolicy.org/fah-weighs-in-with-antitrust-agency-on-health-care-competition-and-transparency/</link>
		<comments>http://fahpolicy.org/fah-weighs-in-with-antitrust-agency-on-health-care-competition-and-transparency/#comments</comments>
		<pubDate>Thu, 22 May 2014 12:00:13 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog Team]]></dc:creator>
				<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=1101</guid>
		<description><![CDATA[The FAH recently attended the Federal Trade Commission’s (FTC) public workshop, Examining Health Care Competition, and commends the FTC for its leadership in exploring an important topic during a time when health care delivery is adapting to critical changes and new structures. Last week, in response to this workshop, the FAH submitted a letter to the FTC to contribute our views on competition in the healthcare marketplace and the role that hospitals play. In our letter, the FAH addresses three main issues: Price transparency; Quality transparency; and, Corporate practice of medicine laws. The first two of these topics were focal points [...] <a href="http://fahpolicy.org/fah-weighs-in-with-antitrust-agency-on-health-care-competition-and-transparency/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/fah-weighs-in-with-antitrust-agency-on-health-care-competition-and-transparency/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Foundation of Quality Hospital Care: NQF-Endorsed Measures</title>
		<link>http://fahpolicy.org/the-foundation-of-quality-hospital-care-nqf-endorsed-measures/</link>
		<comments>http://fahpolicy.org/the-foundation-of-quality-hospital-care-nqf-endorsed-measures/#comments</comments>
		<pubDate>Tue, 21 Jan 2014 14:00:33 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog]]></dc:creator>
				<category><![CDATA[Health Care Delivery]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=865</guid>
		<description><![CDATA[Hospitals’ number one priority is providing high quality care to patients.  To ensure a high standard of quality, hospitals use scientifically valid, well vetted measures, developed by entities such as clinician specialty groups and academic institutions, and endorsed by the National Quality Forum (NQF) to assess their performance in delivering care.  NQF is a nonprofit, membership organization with a three-part mission to support quality improvement in health care by: * Building consensus on national priorities and goals for performance improvement and working in partnership to achieve them; * Endorsing national consensus standards for measuring and publicly reporting on performance; and [...] <a href="http://fahpolicy.org/the-foundation-of-quality-hospital-care-nqf-endorsed-measures/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/the-foundation-of-quality-hospital-care-nqf-endorsed-measures/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Critical Terms and Facts: A Primer for the Upcoming Health Care Transparency Summit</title>
		<link>http://fahpolicy.org/critical-terms-and-facts-a-primer-for-the-upcoming-health-care-transparency-summit/</link>
		<comments>http://fahpolicy.org/critical-terms-and-facts-a-primer-for-the-upcoming-health-care-transparency-summit/#comments</comments>
		<pubDate>Tue, 03 Dec 2013 19:47:00 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog]]></dc:creator>
				<category><![CDATA[Financing]]></category>
		<category><![CDATA[Spending Slowdown]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=803</guid>
		<description><![CDATA[This week, stakeholders from across the health care industry will gather in Washington, D.C. for the National Summit on Health Care Price, Cost and Quality Transparency, a three-day event that will host a variety of panels discussing the many facets of health care financing.  This meeting comes on the heels of news from the White House Council of Economic Advisers who recently released a report highlighting the historic spending slowdown trend in health care, largely attributed to structural changes in our industry. Among the featured speakers at the summit is Steven Brill, author of “A Bitter Pill”, whose article in [...] <a href="http://fahpolicy.org/critical-terms-and-facts-a-primer-for-the-upcoming-health-care-transparency-summit/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/critical-terms-and-facts-a-primer-for-the-upcoming-health-care-transparency-summit/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>FAH Responds to CMS Request for Comment on the Potential Release of Medicare Physician Data</title>
		<link>http://fahpolicy.org/fah-responds-to-cms-request-for-comment-on-the-potential-release-of-medicare-physician-data/</link>
		<comments>http://fahpolicy.org/fah-responds-to-cms-request-for-comment-on-the-potential-release-of-medicare-physician-data/#comments</comments>
		<pubDate>Wed, 11 Sep 2013 17:43:45 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog]]></dc:creator>
				<category><![CDATA[Medicare]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=630</guid>
		<description><![CDATA[Last week, the FAH submitted a letter to Centers for Medicare and Medicaid Services’ Administrator Marilyn Tavenner, in response to the agency’s request for public comment on the additional release of Medicare physician data. Having seen two similar releases by CMS earlier in 2013—that of hospital inpatient and outpatient charge data, respectively—the FAH deemed it critical to weigh in on the possibility of future data being shared to ensure any actions taken by CMS are executed clearly for the sake of patients. In our letter, the FAH outlines several elements that must be considered for any future data releases. Transparency [...] <a href="http://fahpolicy.org/fah-responds-to-cms-request-for-comment-on-the-potential-release-of-medicare-physician-data/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/fah-responds-to-cms-request-for-comment-on-the-potential-release-of-medicare-physician-data/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Measuring Quality &#8211; Supporting Improvement, Transparency and Value</title>
		<link>http://fahpolicy.org/measuring-quality-supporting-improvement/</link>
		<comments>http://fahpolicy.org/measuring-quality-supporting-improvement/#comments</comments>
		<pubDate>Wed, 26 Jun 2013 12:20:55 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog]]></dc:creator>
				<category><![CDATA[Research]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=387</guid>
		<description><![CDATA[More than a decade ago, two seminal Institute of Medicine reports brought to light glaring issues in healthcare quality, issues that were leading to unnecessary and costly medical complications and even the loss of patient lives.  These reports, “To Err is Human” and “Crossing the Quality Chasm” became the rallying cry for transforming our healthcare system from one defined by great variation in care delivery to one based on evidence, metrics and accountability. The loose notion of those concepts from fifteen years ago has been replaced over time with a quality infrastructure that facilitates the endorsement of quality measures by [...] <a href="http://fahpolicy.org/measuring-quality-supporting-improvement/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/measuring-quality-supporting-improvement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Missing Piece for Consumers in the Transparency Puzzle? Health Insurers.</title>
		<link>http://fahpolicy.org/missing-piece-in-transparency/</link>
		<comments>http://fahpolicy.org/missing-piece-in-transparency/#comments</comments>
		<pubDate>Fri, 21 Jun 2013 16:42:25 +0000</pubDate>
		<dc:creator><![CDATA[FAH Hospital Policy Blog]]></dc:creator>
				<category><![CDATA[Affordable Care Act]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Transparency]]></category>

		<guid isPermaLink="false">http://fahpolicy.org/?p=374</guid>
		<description><![CDATA[The U.S. Senate Committee on Finance held a hearing on June 18, 2013, addressing health care price transparency.  We were surprised at those who advocated at the hearing that the Patient Protection and Affordable Care Act (ACA) does not advance meaningful health care transparency.  In fact, the opposite is true.  The ACA has strong and extensive provisions to promote transparency and ensure that consumers receive from health care insurers relevant, up-to-date and useful information about what they will pay for coverage, including out-of-pocket costs.  Effective transparency is critical so that consumers can meaningfully compare health insurance options and make smart [...] <a href="http://fahpolicy.org/missing-piece-in-transparency/">Read More <span class="meta-nav">&#187;</span></a>]]></description>
		<wfw:commentRss>http://fahpolicy.org/missing-piece-in-transparency/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
